Dilated Cardiomyopathy
133
18
21
60
Key Insights
Highlights
Success Rate
88% trial completion (above average)
Published Results
11 trials with published results (8%)
Research Maturity
60 completed trials (45% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
6.0%
8 terminated out of 133 trials
88.2%
+1.7% vs benchmark
12%
16 trials in Phase 3/4
18%
11 of 60 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 60 completed trials
Clinical Trials (133)
Translational Research GRICS-CineCardiac
Dilated Cardiomyopathy-Cardiac Magnetic Resonance (DCM-CMR) Ancillary Study
A Study of AZD4063 in PLN R14del Dilated Cardiomyopathy
Defining the Genetics, Biomarkers and Outcomes for Dilated Cardiomyopathy
Study of the Progression of Chronic Cardiovascular Conditions
A Study to Investigate Safety, Tolerability, and Pharmacokinetics of Oral AZD0233 Compared With Placebo in Healthy Adult Participants.
Clinical Evaluation of the AccuCinch® Ventricular Restoration System in Patients Who Present With Symptomatic Heart Failure With Reduced Ejection Fraction (HFrEF): The CORCINCH-HF Study
Examining the Effects of Mitochondrial Oxidative Stress in DCM
Intraventricular Stasis In Cardiovascular Disease
A Phase 1 Open-Label Study of the Safety of Intravenous Allogeneic Neonatal Mesenchymal Cells (nMSCs) in Young Adult (1A) and Pediatric (1B) Patients With Dilated Cardiomyopathy (DCM)
Use of Bone Marrow Derived Stem Cell and G-CSF With Circulatory Assistance in the Treatment of DCM
Micophenolate Mofetil Versus Azathioprine in Myocarditis
Pediatric Cardiomyopathy Mutation Analysis
Absolute Coronary Flow in Patients With Heart Failure With Reduced Ejection Fraction and Left Bundle Branch Block With Cardiac Resynchronization Therapy
A Clinical Study of Immunoadsorption Therapy for Dilated Cardiomyopathy
Healthy-related Quality of Life and Physical Activity of Children With Cardiac Malformations
UTSW HP [13-C] Pyruvate Injection in HCM
AI-Enabled Direct-from-ECG Ejection Fraction (EF) Severity Assessment Using COR ECG Wearable Monitor
Characterization of Patients With Cardiomyopathy to Identify Critical Patients Candidates for Cardiac Transplantation
Dilated Cardiomyopathy Detection Using AI and Screening With Mobile Technology (DCM-DETECT)